Emerging dimensions of autophagy in melanoma

References

• Switzer B, Puzanov I, Skitzki JJ, et al. Managing metastatic melanoma in 2022: a Clinical Review. JCO Oncol Pract. 2022;18(5):335–351. doi: 10.1200/OP.21.00686
   PubMedGoogle Scholar
• Gray-Schopfer V, Wellbrock C, Marais R, et al. Melanoma biology and new targeted therapy. Nature. 2007;445(7130):851–857. doi: 10.1038/nature05661
   PubMed Web of Science ®Google Scholar
• Davis LE, Shalin SC, Tackett AJ, et al. Current state of melanoma diagnosis and treatment. Cancer Biol Ther. 2019;20(11):1366–1379. doi: 10.1080/15384047.2019.1640032
   PubMed Web of Science ®Google Scholar
• Davies H, Bignell GR, Cox C, et al. Mutations of the BRAF gene in human cancer. Nature. 2002;417(6892):949–954. doi: 10.1038/nature00766
   PubMed Web of Science ®Google Scholar
• Wong DJL, Ribas A. Targeted therapy for melanoma. In: Melanoma Kaufman, H.L. and Mehnert, J.M., eds. Switzerland: Springer International Publishing; 2016. pp. 251–262.
   Google Scholar
• Guo W, Wang H, Li C. Signal pathways of melanoma and targeted therapy. Sig Transduct Target Ther 2021;6(1):424. doi: 10.1038/s41392-021-00827-6
   PubMed Web of Science ®Google Scholar
• Levine B, Klionsky DJ (2017) Autophagy wins the 2016 Nobel Prize in physiology or medicine: breakthroughs in baker’s yeast fuel advances in biomedical research. Proc Natl Acad Sci, USA 114.(2):201–205. doi: 10.1073/pnas.1619876114
   PubMed Web of Science ®Google Scholar
• Deter RL, Baudhuin P, de Duve C, et al. Participation of lysosomes in cellular autophagy induced in rat liver by glucagon. J Cell Bio. 1967;35(2):C11–6. doi: 10.1083/jcb.35.2.C11
   PubMed Web of Science ®Google Scholar
• Tsukada M, Ohsumi Y. Isolation and characterization of autophagy-defective mutants of Saccharomyces cerevisiae. FEBS Lett. 1993;333(1–2):169–174. doi: 10.1016/0014-5793(93)80398-E
   PubMed Web of Science ®Google Scholar
• White E. Deconvoluting the context-dependent role for autophagy in cancer. Nat Rev Cancer. 2012;12(6):401–410. doi: 10.1038/nrc3262
   PubMed Web of Science ®Google Scholar
• Green DR, Levine B. To be or not to be? How selective autophagy and cell death govern cell fate. Cell. 2014;157(1):65–75. doi: 10.1016/j.cell.2014.02.049
   PubMed Web of Science ®Google Scholar
• Feng Y, He D, Yao Z, et al. The machinery of macroautophagy. Cell Res. 2014;24(1):24–41. doi: 10.1038/cr.2013.168
   PubMed Web of Science ®Google Scholar
• Choi AM, Ryter SW, Levine B, et al. Autophagy in human health and disease. N Engl J Med. 2013;368(7):651–662. doi: 10.1056/NEJMra1205406
   PubMed Web of Science ®Google Scholar
• Rahmati M, Ebrahim S, Hashemi S, et al. New insights on the role of autophagy in the pathogenesis and treatment of melanoma. Mol Biol Rep. 2020;47(11):9021–9032. doi: 10.1007/s11033-020-05886-6
   PubMed Web of Science ®Google Scholar
• Yang Z, Klionsky DJ. Mammalian autophagy: core molecular machinery and signaling regulation. Curr Opin Cell Biol. 2010;22(2):124–31. doi: 10.1016/j.ceb.2009.11.014
   PubMed Web of Science ®Google Scholar
• Yamamoto H, Zhang S, Mizushima N, et al. Autophagy genes in biology and disease. Nat Rev Genet. 2023;24(6):382–400. doi: 10.1038/s41576-022-00562-w
   PubMed Web of Science ®Google Scholar
• Trefts E, Shaw RJ. AMPK: restoring metabolic homeostasis over space and time. Mol Cell. 2021;81(18):3677–3690. doi: 10.1016/j.molcel.2021.08.015
   PubMed Web of Science ®Google Scholar
• Glick D, Barth S, Macleod KF, et al. Autophagy: cellular and molecular mechanisms. J Pathol. 2010;221(1):3–12. doi: 10.1002/path.2697
   PubMed Web of Science ®Google Scholar
• Roczniak-Ferguson A, Petit CS, Froehlich F, et al. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci Signal. 2012;5(228):ra42. doi: 10.1126/scisignal.2002790
   PubMed Web of Science ®Google Scholar
• Mizushima N. Autophagy: process and function. Genes Dev. 2007;21(22):2861–73. doi: 10.1101/gad.1599207
   PubMed Web of Science ®Google Scholar
• Kroemer G, Levine B. Autophagic cell death: the story of a misnomer. Nat Rev Mol Cell Biol. 2008;9(12):1004–10. doi: 10.1038/nrm2529
   PubMed Web of Science ®Google Scholar
• Levine B, Yuan J Autophagy in cell death: an innocent convict? J Clin Investig (2005);115(10):2679–2688. doi: 10.1172/JCI26390
   PubMed Web of Science ®Google Scholar
• Debnath J, Gammoh N, Ryan KM, et al. Autophagy and autophagy-related pathways in cancer. Nat Rev Mol Cell Biol. 2023;24(8):560–575. doi: 10.1038/s41580-023-00585-z
   PubMed Web of Science ®Google Scholar
• Liu H, He Z, von Rütte T, et al. Down-regulation of autophagy-related protein 5 (ATG5) contributes to the pathogenesis of early-stage cutaneous melanoma. Sci Transl Med. 2013;5(202):202ra123. doi: 10.1126/scitranslmed.3005864
   PubMed Web of Science ®Google Scholar
• Miracco C, Cevenini G, Franchi A, et al. Beclin 1 and LC3 autophagic gene expression in cutaneous melanocytic lesions. Hum Pathol. 2010;41(4):503–12. doi: 10.1016/j.humpath.2009.09.004
   PubMed Web of Science ®Google Scholar
• Hara Y, Nakamura M. Overexpression of autophagy-related beclin-1 in advanced malignant melanoma and its low expression in melanoma-in-situ. Eur J Dermatol. 2012;22(1):128–9. doi: 10.1684/ejd.2011.1562
   PubMed Web of Science ®Google Scholar
• Liu H, He Z, Simon H-U, et al. Autophagy suppresses melanoma tumorigenesis by inducing senescence. Autophagy. 2014;10(2):372–3. doi: 10.4161/auto.27163
   PubMed Web of Science ®Google Scholar
• Frangež Ž, Gérard D, He Z, et al. ATG5 and ATG7 Expression Levels Are Reduced in Cutaneous melanoma and regulated by NRF1. Front Oncol. 2021;11. doi: 10.3389/fonc.2021.721624
   PubMed Web of Science ®Google Scholar
• Rosenfeldt MT, O’Prey J, Lindsay CR, et al. Loss of autophagy affects melanoma development in a manner dependent on PTEN status. Cell Death Differ. 2021;28(4):1437–1439. doi: 10.1038/s41418-021-00746-7
   PubMed Web of Science ®Google Scholar
• Xie X, Koh JY, Price S, et al. Atg7 overcomes senescence and promotes growth of BrafV600E-driven melanoma. Cancer Discov. 2015;5(4):410–23. doi: 10.1158/2159-8290.CD-14-1473
   PubMed Web of Science ®Google Scholar
• Guo JY, Chen H-Y, Mathew R, et al. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev. 2011;25(5):460–70. doi: 10.1101/gad.2016311
   PubMed Web of Science ®Google Scholar
• Rosenfeldt MT, O’Prey J, Morton JP, et al. p53 status determines the role of autophagy in pancreatic tumour development. Nature 2013;504(7479):296–300. doi: 10.1038/nature12865
   PubMed Web of Science ®Google Scholar
• Yang A, Kimmelman AC. Inhibition of autophagy attenuates pancreatic cancer growth independent of TP53/TRP53 status. Autophagy. 2014;10(9):1683–1684. doi: 10.4161/auto.29961
   PubMed Web of Science ®Google Scholar
• Ma XH, Piao S, Wang D, et al. Measurements of tumor cell autophagy predict invasiveness, resistance to chemotherapy, and survival in melanoma. Clin Cancer Res. 2011;17(10):3478–89. doi: 10.1158/1078-0432.CCR-10-2372
   PubMed Web of Science ®Google Scholar
• Flaherty KT, Puzanov I, Kim KB, et al. Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med. 2010;363(9):809–19. doi: 10.1056/NEJMoa1002011
   PubMed Web of Science ®Google Scholar
• Ma XH, Piao S-F, Dey S, et al. Targeting ER stress–induced autophagy overcomes BRAF inhibitor resistance in melanoma. J Clin Invest 2014;124(3):1406–1417. doi: 10.1172/JCI70454
   PubMed Web of Science ®Google Scholar
• Corazzari M, Rapino F, Ciccosanti F, et al. Oncogenic BRAF induces chronic ER stress condition resulting in increased basal autophagy and apoptotic resistance of cutaneous melanoma. Cell Death Diff. 2015;22(6):946–958. doi: 10.1038/cdd.2014.183
   PubMed Web of Science ®Google Scholar
• Mandula JK, Chang S, Mohamed E, et al. Ablation of the endoplasmic reticulum stress kinase PERK induces paraptosis and type I interferon to promote anti-tumor T cell responses. Cancer Cell. 2022;40(10):1145–1160.e9. doi: 10.1016/j.ccell.2022.08.016
   PubMed Web of Science ®Google Scholar
• Verginadis II, Avgousti H, Monslow J, et al. A stromal Integrated Stress Response activates perivascular cancer-associated fibroblasts to drive angiogenesis and tumour progression. Nat Cell Biol 2022;24(6):940–953. doi: 10.1038/s41556-022-00918-8
   PubMed Web of Science ®Google Scholar
• Yeom H, Hwang S-H, Han B-I, et al. Differential sensitivity of wild-type and BRAF-Mutated cells to combined BRAF and autophagy inhibition. Biomol Ther. 2021;29(4):434–444. doi: 10.4062/biomolther.2020.203
   PubMed Web of Science ®Google Scholar
• Li S, Song Y, Quach C, et al. Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance. Nat Commun. 2019;10(1):1693. doi: 10.1038/s41467-019-09634-8
   PubMedGoogle Scholar
• Settembre C, Medina DL (2015) TFEB and the CLEAR network. Methods Cell Biol 126, 45–62.
   PubMed Web of Science ®Google Scholar
• Chauhan S, Goodwin J, Chauhan S, et al. ZKSCAN3 is a master transcriptional repressor of autophagy. Mol Cell. 2013;50(1):16–28. doi: 10.1016/j.molcel.2013.01.024
   PubMed Web of Science ®Google Scholar
• Marsh T, Kenific CM, Suresh D, et al. Autophagic degradation of NBR1 restricts metastatic outgrowth during mammary tumor progression. Dev Cell. 2020;52(5):591–604.e6. doi: 10.1016/j.devcel.2020.01.025
   PubMed Web of Science ®Google Scholar
• Wei Y, Zou Z, Becker N, et al. EGFR-mediated beclin 1 phosphorylation in autophagy suppression, tumor progression, and tumor chemoresistance. Cell. 2013;154(6):1269–84. doi: 10.1016/j.cell.2013.08.015
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Green DR. Autophagy-independent functions of the autophagy machinery. Cell. 2019;177(7):1682–1699. doi: 10.1016/j.cell.2019.05.026
   PubMed Web of Science ®Google Scholar
• Cao Y, Klionsky DJ. Physiological functions of Atg6/Beclin 1: a unique autophagy-related protein. Cell Res. 2007;17(10):839–49. doi: 10.1038/cr.2007.78
   PubMed Web of Science ®Google Scholar
• Karras P, Riveiro-Falkenbach E, Cañón E, et al. p62/SQSTM1 fuels melanoma progression by opposing mRNA decay of a selective set of pro-metastatic factors. Cancer Cell 2019;35(1):46–63.e10. doi: 10.1016/j.ccell.2018.11.008
   PubMed Web of Science ®Google Scholar
• Zhao Z, Oh S, Li D, et al. A dual role for UVRAG in maintaining chromosomal stability independent of autophagy. Dev Cell. 2012;22(5):1001–16. doi: 10.1016/j.devcel.2011.12.027
   PubMed Web of Science ®Google Scholar
• Yang Y, He S, Wang Q, et al. Autophagic UVRAG Promotes UV-Induced Photolesion Repair by activation of the CRL4(DDB2) E3 ligase. Mol Cell 2016;62(4): 507–519. doi: 10.1016/j.molcel.2016.04.014
   PubMed Web of Science ®Google Scholar
• Di Leo L, Bodemeyer V, Bosisio FM, et al. Loss of Ambra1 promotes melanoma growth and invasion. Nat Commun. 2021;12(1):2550. doi: 10.1038/s41467-021-22772-2
   PubMed Web of Science ®Google Scholar
• Villanueva J, Herlyn M. Melanoma and the tumor microenvironment. Curr Oncol Rep. 2008;10(5):439–46. doi: 10.1007/s11912-008-0067-y
   PubMed Web of Science ®Google Scholar
• Ma Y, Galluzzi L, Zitvogel L, et al. Autophagy and cellular immune responses. Immunity. 2013;39(2):211–27. doi: 10.1016/j.immuni.2013.07.017
   PubMed Web of Science ®Google Scholar
• Zhong Z, Sanchez-Lopez E, Karin M, et al. Autophagy, inflammation, and immunity: a troika governing cancer and its treatment. Cell. 2016;166(2):288–298. doi: 10.1016/j.cell.2016.05.051
   PubMed Web of Science ®Google Scholar
• Luo X, Qiu Y, Dinesh P, et al. The functions of autophagy at the tumour-immune interface. J Cell Mol Med. 2021;25(5):2333–2341. doi: 10.1111/jcmm.16331
   PubMed Web of Science ®Google Scholar
• Shu Q, Zhou Y, Zhu Z, et al. A novel risk Model based on autophagy-related LncRNAs predicts prognosis and indicates immune infiltration landscape of patients with cutaneous melanoma. Front Genet. 2022;13:885391. doi: 10.3389/fgene.2022.885391
   PubMed Web of Science ®Google Scholar
• Zhang C, Sun Y, Li S, et al. Autophagic flux restoration enhances the antitumor efficacy of tumor infiltrating lymphocytes. J Immunother Cancer. 2022;10(10):e004868. doi: 10.1136/jitc-2022-004868
   PubMed Web of Science ®Google Scholar
• Zhang C, Sun Y, Li S, et al. Autophagic flux restoration of senescent T cells improves antitumor activity of TCR-engineered T cells. Clin Transl Immunology. 2022;11(9):e1419. doi: 10.1002/cti2.1419
   PubMed Web of Science ®Google Scholar
• Jin Z, Sun X, Wang Y, et al. Regulation of autophagy fires up the cold tumor microenvironment to improve cancer immunotherapy. Front Immunol. 2022;13:1018903. doi: 10.3389/fimmu.2022.1018903
   PubMedGoogle Scholar
• Prieto K, Lozano MP, Urueña C, et al. The delay in cell death caused by the induction of autophagy by P2Et extract is essential for the generation of immunogenic signals in melanoma cells. Apoptosis. 2020;25(11–12):875–888. doi: 10.1007/s10495-020-01643-z
   PubMed Web of Science ®Google Scholar
• Li Y, Wang L-X, Yang G, et al. Efficient cross-presentation depends on autophagy in tumor cells. Cancer Res. 2008;68(17):6889–95. doi: 10.1158/0008-5472.CAN-08-0161
   PubMed Web of Science ®Google Scholar
• Di Biase S, Lee C, Brandhorst S, et al. Fasting-mimicking diet reduces HO-1 to promote T Cell-mediated tumor cytotoxicity. Cancer Cell. 2016;30(1):136–146. doi: 10.1016/j.ccell.2016.06.005
   PubMed Web of Science ®Google Scholar
• Pietrocola F, Pol J, Kroemer G, et al. Fasting improves anticancer immunosurveillance via autophagy induction in malignant cells. Cell Cycle. 2016;15(24):3327–3328. doi: 10.1080/15384101.2016.1224797
   PubMed Web of Science ®Google Scholar
• Castoldi F, Vacchelli E, Zitvogel L, et al. Systemic autophagy in the therapeutic response to anthracycline-based chemotherapy. Oncoimmunology. 2019;8(1):e1498285. doi: 10.1080/2162402X.2018.1498285
   PubMed Web of Science ®Google Scholar
• Martins I, Michaud M, Sukkurwala AQ, et al. Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death. Autophagy. 2012;8(3):413–5. doi: 10.4161/auto.19009
   PubMed Web of Science ®Google Scholar
• Loi M, Müller A, Steinbach K, et al. Macroautophagy Proteins Control MHC Class I Levels on Dendritic Cells and Shape Anti-viral CD8 + T Cell Responses. Cell Rep 2016;15(5):1076–1087. doi: 10.1016/j.celrep.2016.04.002
   PubMed Web of Science ®Google Scholar
• Munz C. The Macroautophagy Machinery in MHC restricted antigen presentation. Front Immunol. 2021;12:628429. doi: 10.3389/fimmu.2021.628429
   PubMed Web of Science ®Google Scholar
• Yamamoto K, Venida A, Yano J, et al. Autophagy promotes immune evasion of pancreatic cancer by degrading MHC-I. Nature. 2020;581(7806):100–105. doi: 10.1038/s41586-020-2229-5
   PubMed Web of Science ®Google Scholar
• Deng J, Thennavan A, Dolgalev I, et al. ULK1 inhibition overcomes compromised antigen presentation and restores antitumor immunity in LKB1-mutant lung cancer. Nat Cancer 2021;2(5):503–514. doi: 10.1038/s43018-021-00208-6
   PubMedGoogle Scholar
• Poillet-Perez L, Sharp DW, Yang Y, et al. Autophagy promotes growth of tumors with high mutational burden by inhibiting a T-cell immune response. Nat Cancer 20201(9):923–934. doi: 10.1038/s43018-020-00110-7
   PubMedGoogle Scholar
• Qiao Y, Choi JE, Tien JC, et al. Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer. Nat Cancer. 2021;2(9):978–993. doi: 10.1038/s43018-021-00237-1
   PubMedGoogle Scholar
• Lawson KA, Sousa CM, Zhang X, et al. Functional genomic landscape of cancer-intrinsic evasion of killing by T cells. Nature. 2020;586(7827):120–126. doi: 10.1038/s41586-020-2746-2
   PubMed Web of Science ®Google Scholar
• Sharma P, Allison JP. Immune checkpoint targeting in cancer therapy: toward combination strategies with curative potential. Cell. 2015;161(2):205–14. doi: 10.1016/j.cell.2015.03.030
   PubMed Web of Science ®Google Scholar
• Shukla SA, Bachireddy P, Schilling B, et al. Cancer-Germline Antigen Expression Discriminates Clinical Outcome to CTLA-4 Blockade. Cell 2018;173(3):624–633.e8. doi: 10.1016/j.cell.2018.03.026
   PubMed Web of Science ®Google Scholar
• Peng W, Chen JQ, Liu C, et al. Loss of PTEN promotes resistance to T cell–mediated immunotherapy. Cancer Discov 2016;6(2):202–216. doi: 10.1158/2159-8290.CD-15-0283
   PubMed Web of Science ®Google Scholar
• Michaud M, Xie X, Bravo-San Pedro JM, et al. An autophagy-dependent anticancer immune response determines the efficacy of melanoma chemotherapy. Oncoimmunology. 2014;3(7):e944047. doi: 10.4161/21624011.2014.944047
   PubMed Web of Science ®Google Scholar
• Florêncio KGD, Edson EA, Fernandes KSDS, et al. Chromomycin A(5) induces bona fide immunogenic cell death in melanoma. Front Immunol. 2022;13:941757. doi: 10.3389/fimmu.2022.941757
   PubMed Web of Science ®Google Scholar
• Zhou H, Tu C, Yang P, et al. Carbon ion radiotherapy triggers immunogenic cell death and sensitizes melanoma to anti-PD-1 therapy in mice. Oncoimmunology. 2022;11(1):2057892. doi: 10.1080/2162402X.2022.2057892
   PubMed Web of Science ®Google Scholar
• Tschernia NP, Gulley JL. Tumor in the Crossfire: inhibiting TGF-β to enhance cancer immunotherapy. BioDrugs. 2022;36(2):153–180. doi: 10.1007/s40259-022-00521-1
   PubMed Web of Science ®Google Scholar
• Tauriello DVF, Palomo-Ponce S, Stork D, et al. TGFβ drives immune evasion in genetically reconstituted colon cancer metastasis. Nature 2018;554(7693):538–543. doi: 10.1038/nature25492
   PubMed Web of Science ®Google Scholar
• Horn LA, Chariou PL, Gameiro SR, et al. Remodeling the tumor microenvironment via blockade of LAIR-1 and TGF-β signaling enables PD-L1–mediated tumor eradication. J Clin Invest. 2022;132(8). doi: 10.1172/JCI155148
   PubMed Web of Science ®Google Scholar
• Chen D, Xie J, Fiskesund R, et al. Publisher correction: chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nat Commun. 2018;9(1):1808. doi: 10.1038/s41467-018-04169-w
   PubMedGoogle Scholar
• Chen D, Xie J, Fiskesund R, et al. Chloroquine modulates antitumor immune response by resetting tumor-associated macrophages toward M1 phenotype. Nat Commun. 2018;9(1):873. doi: 10.1038/s41467-018-03225-9
   PubMed Web of Science ®Google Scholar
• Gartrell-Corrado RD, Chen AX, Rizk EM, et al. Linking transcriptomic and imaging data defines features of a favorable tumor immune microenvironment and identifies a combination biomarker for primary melanoma. Cancer Res. 2020;80(5):1078–1087. doi: 10.1158/0008-5472.CAN-19-2039
   PubMed Web of Science ®Google Scholar
• Mgrditchian T, Arakelian T, Paggetti J, et al. Targeting autophagy inhibits melanoma growth by enhancing NK cells infiltration in a CCL5-dependent manner. Proc Natl Acad Sci USA. 2017;114(44):E9271–e9279. doi: 10.1073/pnas.1703921114
   PubMed Web of Science ®Google Scholar
• Wang S, Xia P, Huang G, et al. FoxO1-mediated autophagy is required for NK cell development and innate immunity. Nat Commun. 2016;7(1):11023. doi: 10.1038/ncomms11023
   PubMedGoogle Scholar
• Seo W, Shimizu K, Kojo S, et al. Runx-mediated regulation of CCL5 via antagonizing two enhancers influences immune cell function and anti-tumor immunity. Nat Commun. 2020;11(1):1562. doi: 10.1038/s41467-020-15375-w
   PubMed Web of Science ®Google Scholar
• Levine B, Kroemer G. Autophagy in the pathogenesis of disease. Cell. 2008;132(1):27–42. doi: 10.1016/j.cell.2007.12.018
   PubMed Web of Science ®Google Scholar
• Petherick KJ, Conway OJL, Mpamhanga C, et al. Pharmacological inhibition of ULK1 kinase blocks mammalian target of rapamycin (mTOR)-dependent autophagy. J Biol Chem. 2015;290(18):11376–83. doi: 10.1074/jbc.C114.627778
   PubMed Web of Science ®Google Scholar
• Lazarus MB, Shokat KM. Discovery and structure of a new inhibitor scaffold of the autophagy initiating kinase ULK1. Bioorg Med Chem. 2015;23(17):5483–8. doi: 10.1016/j.bmc.2015.07.034
   PubMed Web of Science ®Google Scholar
• Egan DF, Chun MH, Vamos M, et al. Small molecule inhibition of the autophagy kinase ULK1 and identification of ULK1 substrates. Mol Cell. 2015;59(2):285–97. doi: 10.1016/j.molcel.2015.05.031
   PubMed Web of Science ®Google Scholar
• Chaikuad A, Koschade SE, Stolz A, et al. Conservation of structure, function and inhibitor binding in UNC-51-like kinase 1 and 2 (ULK1/2). Biochem J. 2019;476(5):875–887. doi: 10.1042/BCJ20190038
   PubMedGoogle Scholar
• Tolcher AW, Hong DS, Vandross AL, et al. A phase 1/2 study of DCC-3116 as a single agent and in combination with trametinib in patients with advanced or metastatic solid tumors with RAS or RAF mutations. J Clin Oncol. 2022;40(16_suppl):TPS3178–TPS3178. doi: 10.1200/JCO.2022.40.16_suppl.TPS3178
   Web of Science ®Google Scholar
• Bago R, Malik N, Munson M, et al. Characterization of VPS34-IN1, a selective inhibitor of Vps34, reveals that the phosphatidylinositol 3-phosphate-binding SGK3 protein kinase is a downstream target of class III phosphoinositide 3-kinase. Biochem J. 2014;463(3):413–27. doi: 10.1042/BJ20140889
   PubMed Web of Science ®Google Scholar
• Ronan B, Flamand O, Vescovi L, et al. A highly potent and selective Vps34 inhibitor alters vesicle trafficking and autophagy. Nat Chem Biol. 2014;10(12):1013–9. doi: 10.1038/nchembio.1681
   PubMed Web of Science ®Google Scholar
• Amaravadi RK, Lippincott-Schwartz J, Yin X-M, et al. Principles and current strategies for targeting autophagy for cancer treatment. Clin Cancer Res. 2011;17(4):654–66. doi: 10.1158/1078-0432.CCR-10-2634
   PubMed Web of Science ®Google Scholar
• Xie X, White EP, Mehnert JM, et al. Coordinate autophagy and mTOR pathway inhibition enhances cell death in melanoma. PloS One. 2013;8(1):e55096. doi: 10.1371/journal.pone.0055096
   PubMed Web of Science ®Google Scholar
• Chude CI, Amaravadi RK. Targeting autophagy in cancer: update on clinical trials and novel inhibitors. Int J Mol Sci. 2017;18(6):1279. doi: 10.3390/ijms18061279
   PubMed Web of Science ®Google Scholar
• Mehnert JM, Mitchell TC, Huang AC, et al. BAMM (BRAF autophagy and MEK inhibition in melanoma): a phase I/II trial of Dabrafenib, trametinib, and hydroxychloroquine in advanced BRAFV600-mutant melanoma. Clin Cancer Res. 2022;28(6):1098–1106. doi: 10.1158/1078-0432.CCR-21-3382
   PubMed Web of Science ®Google Scholar
• Awada G, Schwarze JK, Tijtgat J, et al. A lead-in safety study followed by a phase 2 clinical trial of dabrafenib, trametinib and hydroxychloroquine in advanced BRAFV600 mutant melanoma patients previously treated with BRAF-/MEK-inhibitors and immune checkpoint inhibitors. Melanoma Res. 2022;32(3):183–191. doi: 10.1097/CMR.0000000000000821
   PubMed Web of Science ®Google Scholar
• Maycotte P, Aryal S, Cummings CT, et al. Chloroquine sensitizes breast cancer cells to chemotherapy independent of autophagy. Autophagy. 2012;8(2):200–12. doi: 10.4161/auto.8.2.18554
   PubMed Web of Science ®Google Scholar
• Eng CH, Wang Z, Tkach D, et al. Macroautophagy is dispensable for growth of KRAS mutant tumors and chloroquine efficacy. Proc Natl Acad Sci U S A. 2016;113(1):182–7. doi: 10.1073/pnas.1515617113
   PubMed Web of Science ®Google Scholar
• Maes H, Kuchnio A, Peric A, et al. Tumor vessel normalization by chloroquine independent of autophagy. Cancer Cell. 2014;26(2):190–206. doi: 10.1016/j.ccr.2014.06.025
   PubMed Web of Science ®Google Scholar
• Kroemer G, Jaattela M. Lysosomes and autophagy in cell death control. Nat Rev Cancer. 2005;5(11):886–97. doi: 10.1038/nrc1738
   PubMed Web of Science ®Google Scholar
• Gallagher LE, Radhi OA, Abdullah MO, et al. Lysosomotropism depends on glucose: a chloroquine resistance mechanism. Cell Death Dis. 2017;8(8):e3014. doi: 10.1038/cddis.2017.416
   PubMedGoogle Scholar
• Luciani F, Spada M, De Milito A, et al. Effect of proton pump inhibitor pretreatment on resistance of solid tumors to cytotoxic drugs. J Natl Cancer Inst. 2004;96(22):1702–13. doi: 10.1093/jnci/djh305
   PubMed Web of Science ®Google Scholar
• Zhitomirsky B, Assaraf YG. Lysosomal accumulation of anticancer drugs triggers lysosomal exocytosis. Oncotarget. 2017;8(28):45117–45132. doi: 10.18632/oncotarget.15155
   PubMedGoogle Scholar
• Rebecca VW, Nicastri MC, Fennelly C, et al. PPT1 promotes tumor growth and is the molecular target of chloroquine derivatives in cancer. Cancer Discov. 2019;9(2):220–229. doi: 10.1158/2159-8290.CD-18-0706
   PubMed Web of Science ®Google Scholar
• Lakhter AJ, Sahu RP, Sun Y, et al. Chloroquine promotes apoptosis in melanoma cells by inhibiting BH3 domain–mediated PUMA degradation. J Invest Dermatol 2013;133(9):2247–2254. doi: 10.1038/jid.2013.56
   PubMed Web of Science ®Google Scholar
• Accapezzato D, Visco V, Francavilla V, et al. Chloroquine enhances human CD8+ T cell responses against soluble antigens in vivo. J Exp Med. 2005;202(6):817–28. doi: 10.1084/jem.20051106
   PubMed Web of Science ®Google Scholar
• Tian AL, Wu Q, Liu P, et al. Lysosomotropic agents including azithromycin, chloroquine and hydroxychloroquine activate the integrated stress response. Cell Death Dis. 2021;12(1):6. doi: 10.1038/s41419-020-03324-w
   PubMed Web of Science ®Google Scholar
• Humeau J, Bezu L, Kepp O, et al. EIF2α phosphorylation: a hallmark of both autophagy and immunogenic cell death. Mol Cell Oncol 2020;7(5):1776570. doi: 10.1080/23723556.2020.1776570
   PubMed Web of Science ®Google Scholar
• Zhitomirsky B, Yunaev A, Kreiserman R, et al. Lysosomotropic drugs activate TFEB via lysosomal membrane fluidization and consequent inhibition of mTORC1 activity. Cell Death Dis. 2018;9(12):1191. doi: 10.1038/s41419-018-1227-0
   PubMedGoogle Scholar
• Humeau J, Sauvat A, Kepp O, et al. An unexpected link between immunogenic cell death and inhibition of gene transcription. Oncoimmunology. 2020;9(1):1792039. doi: 10.1080/2162402X.2020.1792039
   PubMed Web of Science ®Google Scholar
• Vakifahmetoglu-Norberg H, Xia H-G, Yuan J, et al. Pharmacologic agents targeting autophagy. J Clin Invest. 2015;125(1):5–13. doi: 10.1172/JCI73937
   PubMed Web of Science ®Google Scholar
• Galluzzi L, Bravo-San Pedro JM, Levine B, et al. Pharmacological modulation of autophagy: therapeutic potential and persisting obstacles. Nat Rev Drug Discov. 2017;16(7):487–511. doi: 10.1038/nrd.2017.22
   PubMed Web of Science ®Google Scholar
• Shoji-Kawata S, Sumpter R, Leveno M, et al. Identification of a candidate therapeutic autophagy-inducing peptide. Nature. 2013;494(7436):201–6. doi: 10.1038/nature11866
   PubMed Web of Science ®Google Scholar
• Vega-Rubin-de-Celis S, Zou Z, Fernández ÁF, et al. Increased autophagy blocks HER2-mediated breast tumorigenesis. Proc Natl Acad Sci U S A. 2018;115(16):4176–4181. doi: 10.1073/pnas.1717800115
   PubMed Web of Science ®Google Scholar
• Wang C, Niederstrasser H, Douglas PM, et al. Small-molecule TFEB pathway agonists that ameliorate metabolic syndrome in mice and extend C. elegans lifespan. Nat Commun. 2017;8(1):2270. doi: 10.1038/s41467-017-02332-3
   PubMedGoogle Scholar
• Frankel AE, Eskiocak U, Gill JG, et al. Digoxin plus trametinib therapy achieves disease control in BRAF wild-type metastatic melanoma patients. Neoplasia. 2017;19(4):255–260. doi: 10.1016/j.neo.2017.01.010
   PubMed Web of Science ®Google Scholar